A

AprilBio Co Ltd
KOSDAQ:397030

Watchlist Manager
AprilBio Co Ltd
KOSDAQ:397030
Watchlist
Price: 48 800 KRW 2.74% Market Closed
Market Cap: 1.1T KRW

Relative Value

The Relative Value of one AprilBio Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 48 800 KRW, AprilBio Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AprilBio Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
27
vs Industry
34
Median 3Y
24.8
Median 5Y
21.9
Industry
7.9
Forward
58.8
vs History
0
vs Industry
4
Median 3Y
13.8
Median 5Y
13.8
Industry
23.7
Forward
89.6
vs History
4
vs Industry
5
Median 3Y
-10.6
Median 5Y
0
Industry
22
vs History
20
vs Industry
10
Median 3Y
20.3
Median 5Y
20.3
Industry
24.3
vs History
0
vs Industry
21
Median 3Y
4.3
Median 5Y
4.2
Industry
3.3
vs History
27
vs Industry
32
Median 3Y
21.9
Median 5Y
18.1
Industry
8.2
Forward
53.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.2
vs History
vs Industry
7
Median 3Y
-14.8
Median 5Y
-10.6
Industry
6.1
Forward
110.8
vs History
vs Industry
6
Median 3Y
-14
Median 5Y
-10
Industry
6.5
Forward
124.6
vs History
4
vs Industry
6
Median 3Y
-4.9
Median 5Y
0
Industry
7.9
vs History
4
vs Industry
5
Median 3Y
-4.8
Median 5Y
0
Industry
6.3
vs History
0
vs Industry
15
Median 3Y
49
Median 5Y
49
Industry
5.7

Multiples Across Competitors

Competitors Multiples
AprilBio Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
AprilBio Co Ltd
KOSDAQ:397030
1.1T KRW 122.5 1 145.8 -1 179.4 -651
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 667 065.8 -160 014.6 -194 308.7 -192 091.4
US
Abbvie Inc
NYSE:ABBV
406.5B USD 6.8 173.1 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
179.1B USD 5 25.6 18.4 18.4
US
Gilead Sciences Inc
NASDAQ:GILD
154.9B USD 5.3 19.1 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.6B USD 10 32 23.5 24.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 092.5 -534 -581.4 -565.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.7B USD 5.8 18.1 17.3 19.6
AU
CSL Ltd
ASX:CSL
83B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.8B USD 16.4 1 211.8 163.4 198.2
NL
argenx SE
XBRU:ARGX
44B EUR 14.4 33.8 58.2 59.8
P/E Multiple
Earnings Growth PEG
KR
A
AprilBio Co Ltd
KOSDAQ:397030
Average P/E: 297.5
1 145.8
1%
1 145.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 014.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
173.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.6
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19.1
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 211.8
N/A N/A
NL
argenx SE
XBRU:ARGX
33.8
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
A
AprilBio Co Ltd
KOSDAQ:397030
Average EV/EBITDA: 40.4
Negative Multiple: -1 179.4
-1%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 308.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.4
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
11%
1.6
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.4
N/A N/A
NL
argenx SE
XBRU:ARGX
58.2
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
A
AprilBio Co Ltd
KOSDAQ:397030
Average EV/EBIT: 46.6
Negative Multiple: -651
-1%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 091.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.4
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.6
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198.2
N/A N/A
NL
argenx SE
XBRU:ARGX
59.8
N/A N/A